lutein has been researched along with Choroid Neovascularization in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Agrón, E; Antoszyk, AN; Chew, EY; Clemons, TE; Domalpally, A; Elman, MJ; Keenan, TD; Vitale, S | 1 |
| Chen, S; Connor, KM; Kimura, K; Nanri, T; Uchi, SH; Yanai, R | 1 |
| Fernández-García, V; Fernández-Robredo, P; García-García, L; García-Layana, A; Heras-Mulero, H; Ivanescu, AA; Moreno-Orduna, M; Recalde, S; Redondo-Exposito, A; Sádaba-Echarri, LM | 1 |
| Cruysberg, JR; Theelen, T; Willemsen, MA | 1 |
| Hawkins, WR | 1 |
| Bartz-Schmidt, KU; Berendschot, TT; Gelisken, F; Kanis, MJ; Reinhard, J; Schön, C; Trauzettel-Klosinski, S; Zrenner, E | 1 |
| Chew, EY; Clemons, TE; Ferris, FL; Gensler, G; Lindblad, AS; Milton, RC; SanGiovanni, JP; Seddon, JM; Sperduto, RD | 1 |
| Ishida, S; Izumi-Nagai, K; Nagai, N; Ohgami, K; Ohno, S; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K; Umezawa, K | 1 |
1 trial(s) available for lutein and Choroid Neovascularization
| Article | Year |
|---|---|
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Female; Follow-Up Studies; Humans; Intravitreal Injections; Lutein; Male; Middle Aged; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2020 |
7 other study(ies) available for lutein and Choroid Neovascularization
| Article | Year |
|---|---|
Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice.
Topics: Administration, Oral; Animals; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Gene Expression Regulation; Laser Coagulation; Lutein; Mice; NADPH Oxidase 4; Reactive Oxygen Species | 2018 |
Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.
Topics: Animals; Carrier Proteins; Choroid; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorescein Angiography; Intravitreal Injections; Lutein; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Minerals; NLR Family, Pyrin Domain-Containing 3 Protein; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Vitamins | 2015 |
Macular fibrosis complicating macular pigment deficient maculopathy in Sjögren-Larsson syndrome.
Topics: Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Female; Fibrosis; Fluorescein Angiography; Humans; Intravitreal Injections; Lutein; Macula Lutea; Sjogren-Larsson Syndrome; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Young Adult; Zeaxanthins | 2016 |
Lutein/zeaxanthin.
Topics: Atrophy; Choroidal Neovascularization; Diet; Humans; Lutein; Macular Degeneration; Pigment Epithelium of Eye; Retinal Drusen; Vitamins; Xanthophylls; Zeaxanthins | 2008 |
Macular pigment and fixation after macular translocation surgery.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Fixation, Ocular; Fovea Centralis; Humans; Lutein; Macula Lutea; Middle Aged; Retinal Pigments; Visual Acuity; Visual Field Tests | 2010 |
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Carotenoids; Case-Control Studies; Choroidal Neovascularization; Diet; Eating; Energy Intake; Feeding Behavior; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrition Surveys; Regression Analysis; Surveys and Questionnaires; Vitamin A; Vitamin E; Xanthophylls; Zeaxanthins | 2007 |
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Choroid; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Laser Coagulation; Lutein; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-KappaB Inhibitor alpha; Reproducibility of Results; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2007 |